华厦眼科 (301267.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

15.0x

Market Cap

CNY 13.29B

MomentumView details →

1D Return

−1.37%

YTD Return

−15.85%

RSI (14)

39.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

15.0x

Market Cap

CNY 13.29B

RSI (14)

39.8

MomentumView details →

1D Return

−1.37%

YTD Return

−15.85%

ProfitabilityView details →

Gross Margin

43.65%

Net Margin

11.03%

EBITDA Margin

20.53%

ROE (TTM)

8.50%

ROA (TTM)

6.00%

Asset Turnover

0.55x

GrowthView details →

Revenue YoY

+1.31%

EPS YoY

+8.68%

FCF YoY

+20.48%

Revenue CAGR 3Y

+8.58%

EPS CAGR 3Y

−7.52%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.16x

Current Ratio

3.82x

Quick Ratio

3.68x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

4.20B

Net Income (TTM)

462.64M

Op. CF (TTM)

943.26M

Latest newsMore news →

Huaxia Eye Hospital's actual controller Su Qingcan plans to increase his stake in the company by at least 30 million yuan from September 2 to December 1, 2026.3d ago

Huaxia Eye Hospital's shareholder Xiamen Hanwei Equity Investment Partnership plans to reduce its stake by up to 1.49% within three months.9d ago

Similar companies

迪安诊断300244.SZ 三博脑科301293.SZ 美年健康002044.SZ 国际医学000516.SZ 创新医疗002173.SZ 新里程002219.SZ

Latest newsMore news →

Huaxia Eye Hospital's actual controller Su Qingcan plans to increase his stake in the company by at least 30 million yuan from September 2 to December 1, 2026.3d ago Huaxia Eye Hospital's shareholder Xiamen Hanwei Equity Investment Partnership plans to reduce its stake by up to 1.49% within three months.9d ago